Title:
【発明の名称】重抑鬱障害の治療のためのNK-1受容体拮抗薬の使用
Document Type and Number:
Japanese Patent JP2001504847
Kind Code:
A
Abstract:
The present invention provides the use of a CNS-penetrant NK-1 receptor antagonist in an oral, once-a-day medicament for the treatment of major depressive disorder, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.
Inventors:
Baker, Raymond
Carteis, Nail Roy
Elliott, The Eason Machine
Harrison, Tamothy
Haringworth, Gregory Jiyoung
Jackson, Philip Stephen
Kragowski, Janus Joseph
Rudniyatsk, Nadya Melanii
Suede, Irene Mary
Swain, Christopher Jiyoung
Williams, Brian Jiyoung
Carteis, Nail Roy
Elliott, The Eason Machine
Harrison, Tamothy
Haringworth, Gregory Jiyoung
Jackson, Philip Stephen
Kragowski, Janus Joseph
Rudniyatsk, Nadya Melanii
Suede, Irene Mary
Swain, Christopher Jiyoung
Williams, Brian Jiyoung
Application Number:
JP52516998A
Publication Date:
April 10, 2001
Filing Date:
November 25, 1997
Export Citation:
Assignee:
Merck Sharp End Dome Limited
International Classes:
A61K31/00; A61K31/395; A61K31/4015; A61K31/438; A61K31/445; A61K31/451; A61K31/535; A61K31/5375; A61K31/5377; A61K31/675; A61K45/00; A61P25/24; C07D211/56; C07D265/32; C07D413/06; C07D491/10; (IPC1-7): A61K45/00; A61K31/4015; A61P25/24
Attorney, Agent or Firm:
Yoshio Kawaguchi (2 outside)